Structural basis of kynurenine 3-monooxygenase inhibition

Inhibition of kynurenine 3-monooxygenase (KMO), an enzyme in the eukaryotic tryptophan catabolic pathway (i.e. kynurenine pathway), leads to amelioration of Huntington’s disease-relevant phenotypes in yeast, fruit fly, and mouse models(1–5), as well as a mouse model of Alzheimer’s disease(3). KMO is...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaral, Marta, Levy, Colin, Heyes, Derren J., Lafite, Pierre, Outeiro, Tiago F., Giorgini, Flaviano, Leys, David, Scrutton, Nigel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736096/
https://www.ncbi.nlm.nih.gov/pubmed/23575632
http://dx.doi.org/10.1038/nature12039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736096/
https://www.ncbi.nlm.nih.gov/pubmed/23575632
http://dx.doi.org/10.1038/nature12039

Ejemplares similares